PlumX Metrics
Embed PlumX Metrics

Acetylator polymorphism in Parkinson's disease

European Journal of Clinical Pharmacology, ISSN: 0031-6970, Vol: 37, Issue: 4, Page: 391-393
1989
  • 19
    Citations
  • 0
    Usage
  • 4
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Acetylator phenotype has been determined using sulphamethazine in 100 patients with Parkinson's disease and in 93 age-matched normal control subjects. Sixty-nine patients and 54 control subjects were classified as slow acetylators (NS). No relation was found among acetylator polymorphism and age at onset or clinical stage of disease. Amongst slow acetylators, the percentage of acetylated sulphamethazine in plasma was significantly lower in patients than in controls. Despite this finding, the results do not support any relationship between acetylator polymorphism and the risk of developing Parkinson's disease. © 1989 Springer-Verlag.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know